ARMK · Aramark
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Earnings Per Share Growth (Constant Currency), without the calendar shift non-GAAP | 42.9% | Three Months Ended July 3, 2026 | — |
| Adjusted Net Income (Constant Currency), without the calendar shift non-GAAP | 154.1M | Three Months Ended July 3, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Adjusted Net Income, without the calendar shift 155.03M
-930K Effect of Currency Translation, net of Tax
= Adjusted Net Income (Constant Currency), without the calendar shift 154.1M
|
|||
| Adjusted Operating Income (Constant Currency), without the calendar shift non-GAAP | 279.49M | Three Months Ended July 3, 2026 | — |
| Adjusted Operating Income Growth (Constant Currency), without the calendar shift non-GAAP | 21.4% | Three Months Ended July 3, 2026 | — |
| Adjusted Operating Income Margin (Constant Currency), without the calendar shift non-GAAP | 5.5% | Three Months Ended July 3, 2026 | — |
| Free Cash Flow | -597.24M | Nine Months Ended June 27, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ARMK
this stock
Aramark
|
$14.63B | +49.1% | +6.4% | 38.8 | 3.0% |
|
CTAS
Cintas Corp
|
$80.33B | +7.6% | +6.4% | 39.9 | 3.2% |
|
RELX
Relx PLC
|
$62.78B | -10.6% | — | — | 0.4% |
|
TRI
Thomson Reuters Corp /Can/
|
$44.72B | -21.7% | — | — | 3.0% |
|
CPRT
Copart Inc
|
$25.25B | -30.2% | +24.7% | 17.6 | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ARMK | -1.1% | -6.2% | +20.5% | +2.6% | +49.1% |
| SPY | +1.2% | +1.9% | +9.9% | +2.1% | +14.2% |
| vs SPY | -2.3% | -8.0% | +10.6% | +0.5% | +34.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.